Restoring Calm,

Reclaiming Lives

Transforming the treatment of PTSD through expert-driven bioelectronic innovation

Partner with us
About us
Read our insights

Post-traumatic stress disorder represents one of the most significant unmet medical needs globally, affecting millions while treatment options remain limited.

The PTSD Crisis

24M

ADULTS AFFECTED (EU+US)

50%

TREATMENT-RESISTANT DESPITE STANDARD CARE

$350B

GLOBAL SOCIETAL COST ANNUALLY

3X

INCREASED OPIOD DEPENDENCY RISK

Understanding PTSD Burden

  • Clinical Manifestation: Intrusive memories, nightmares, hyperarousal, avoidance behaviors, and emotional dysregulation persist despite current gold-standard therapies including SSRIs and trauma-focused psychotherapy.

  • Neurobiological Reality: PTSD is fundamentally a dysregulation of the autonomic nervous system, where the body's "fight-or-flight" response remains locked in an activated state long after threat has passed.

  • Economic & Human Cost: Beyond healthcare expenses, PTSD drives disability, lost productivity, increased opioid utilization, and tragically, elevated suicide risk (+22%).

  • Military Population: Service members face 2–8× higher prevalence than civilians, with lasting impact on readiness, retention, and long-term health.

A New Paradigm in PTSD Treatment

A first-in-class therapy that addresses PTSD at its source — not just the symptoms.

Our Solution

Stimalia is developing a minimally invasive, drug-free approach that targets the autonomic nervous system directly — calming the body's stress response where it originates.

Why It Works

Built on decades of clinical research showing 70–80% of patients experience meaningful relief when the sympathetic “alarm system” is addressed at its source.

What Makes Us Different.

One outpatient procedure — no daily pills, no repeat injections

Drug-free — no systemic side effects

Personalized — tailored to each patient's needs

Durable — designed for long-term benefit

Leadership and Expertise

A team of seasoned neuromodulation, medical device, and clinical experts dedicated to solving the PTSD crisis.

  • CEO & Co-Founder

    25+ years of MedTech leadership in neuromodulation, minimally invasive surgery, and digital health. Founded MONA.health (AI in ophthalmology). Former CEO at Man&Science. Drives strategy, fundraising, and commercial partnerships.

  • CTO & Co-Founder

    25+ years pioneering neurostimulation R&D; co-inventor on 300+ patent claims. Co-founder and CTO at Synergia Medical. Oversees device architecture, miniaturization, and regulatory engineering.

  • CC & Co-Founder

    25+ years in neurovascular and cardiovascular innovation (Boston Scientific, Edwards LifeSciences, Stryker, Penumbra). Drives clinical affairs, key opinion leader relationships, and scientific communication.

PTSD Insights & Research

Thought leadership on the neurobiological basis of PTSD, clinical evidence, and the future of trauma-informed care.

  • PTSD & the Autonomic Nervous System

    Understanding the Sympathetic Overdrive in PTSD

    Why hyperarousal, insomnia, and physiological dysregulation persist—and how targeting the sympathetic nervous system offers a novel therapeutic pathway.

    Read Article →

  • Stellate Ganglion Block

    Coming soon

    Stellate Ganglion Block: A Paradigm Shift in PTSD Treatment

    Clinical evidence overview: Why 70–80% of patients experience meaningful symptom reduction, and why continuous stimulation could extend this benefit.

    Read Article →

  • Military: PTSD & Readiness

    Coming soon

    PTSD in Military Populations: Burden, Opportunity, and Innovation

    Why veterans and service members represent both the highest-need and highest-impact population for breakthrough PTSD interventions.

    Read Article →

  • The Hidden Crisis in Elite Sports

    1 in 8 elite athletes suffers from PTSD. Most will never tell you.

    We celebrate their victories and admire their mental toughness. But behind the medals, millions of athletes are trapped in bodies that won't stop fighting invisible threats. The science now shows why, and it's not what you think.

    Read Article →

Get In Touch

Interested in partnership, investment, or collaboration? Let's talk about the future of PTSD treatment.

Join Us